Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Intrexon (XON) +4.8% AH after David Einhorn's Greenlight

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dav1234 Member Profile
 
Followed By 121
Posts 93,348
Boards Moderated 4
Alias Born 10/29/07
160x600 placeholder
S&P 500 Posts Biggest Weekly Gain Of 2014
U.S. stocks closed with solid gains Friday, leaving the S&P 500 with its largest weekly advance of the year.
Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
Microsoft Gains Help Lead Tech's Advance
Treasury Bonds Pull Back for Second Straight Day
Will Free Data Become the Next Free Shipping?
Microsoft Braces for Another Nokia Hit--Earnings Preview
Procter & Gamble Looking at Margins, Brands--Earnings Preview
Pfizer Results Will Play Second Fiddle to Dealmaking Outlook -- Earnings Preview
Stifel Financial to Hire Two Former Merrill Lynch Advisers
dav1234   Thursday, 11/14/13 06:09:02 PM
Re: None
Post # of 183180 
Intrexon (XON) +4.8% AH after David Einhorn's Greenlight Capital reveals it opened a ~2.1M-share position in the biotech company that went public in August

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist